The role of ICAM-1 on T-cells in the pathogenesis of asthma

European Respiratory Journal

Volumn 11, Issue 4, 1998, Pages 949-957

  Stanciu, L A ^a   Djukanovic, R ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Intercellular adhesion molecule 1; T cells

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ASTHMA; CELL ADHESION; CELL PROLIFERATION; CYTOTOXICITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATORY CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; T LYMPHOCYTE ACTIVATION; TARGET CELL; VASCULAR ENDOTHELIUM;

ANTIGEN-PRESENTING CELLS; ASTHMA; CHILD; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; T-LYMPHOCYTES;

EID: 0031747530     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11040949     Document Type: Review

References (100)

1. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulins and integrin supergene families. Cell 1988; 52: 925-933.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
3. Lloyd AR, Oppenheim JJ, Kelvin DJ, Taub DD. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 1996; 156: 932-938.
4. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PK. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transmigration of human T lymphocytes. J Immunol 1991; 147: 2913-2921.
5. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, and Dustin ML. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med 1995; 182: 1231-1241.
6. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-1896.
7. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767-804.
8. Delneste Y, Jeannin P, Gosset P, et al. Allergen-stimulated T lymphocytes from allergic patients induce vascular cell adhesion molecule-1 (VCAM-1) expression and IL-6 production by endothelial cells. Clin Exp Immunol 1995; 101: 164-171.
9. Mobley JL, Rigby SM, Dailey MO. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolitic T cells responding to minor antigens. J Immunol 1994; 153: 5443-5452.
10. Picker LJ, Terstappen LWMM, Rott LS, Streeter PR, Stein H, Butcher EC. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 1990; 145: 3247-3255.
11. Buckle AM, Hogg N. Human memory T cells express intercellular molecule-1 which can be increased by interleukin 2 and interferon-γ. Eur J Immunol 1990; 20: 337-341.
12. MEL-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4α during the differentiation of cytotoxic T lymphocytes induced by allografts. J Immunol 1992; 148: 2348-2356.
13. Louis R, Shute J, Biagi S, et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 1997; 155: 466-472.
14. Berg EL, Yoshino T, Rott LS, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174: 1461-1466.
15. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-19. Nature 1993; 361: 79-82.
16. Ortiz BD, Nelson PJ, Krensky AM. Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today 1997; 18: 468-471.
17. Cruikshank WW, Greenstein JL, Theodore AC, Center DM. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmatic signaling in lymphocytes. J Immunol 1991; 146: 2928-2934.
18. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
19. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6: 865-873.
20. Kennedy J, Kelner GS, Kleyensteuber S, et al. Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995; 155: 203-209.
21. Wilkinson PC, Liew FY. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995; 181: 1255-1259.
22. Nieto M, del Pozo MA, Sanchez-Madrid F. Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur J Immunol 1996; 26: 1302-1307.
23. Qin S, La Rosa G, Campbell JJ, et al. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol 1996; 26: 640-647.
24. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005-2007.
25. Campbell JJ, Qin S, Bacon KB, Mackay CR, Butcher EC. Biology of chemokine and classical chemoattractant receptors: differential requirement for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol 1996; 134: 255-266.
26. Honda S, Campbell JJ, Andrew DP, et al. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor. J Immunol 1994; 152: 4026-4035.
27. Carr MW, Alon R, Springer TA. The C-C-chemokine MCP-1 differentially modulates the avidity of β1 and β2 integrins on T lymphocytes. Immunity 1996; 4: 179-187.
28. Gilat D, Hershkoviz R, Mekori YA, Vlodavsky I, Lider O. Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J Immunol 1994; 153: 4899-4906.
29. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential differentiation of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 1993; 260: 355-358.
30. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. J Cell Biol 1995; 131: 495-508.
31. del Pozo MA, Cabanas C, Montoya MC, Ager A, Sanchez-Mateos P, Sanchez-Madrid F. ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 1997; 137: 493-508.
32. Loetscher P, Seitz M, Baggiolini M, Moser M. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996; 184: 569-577.
33. Mackay CR. Chemokine receptors and T cell chemotaxis. J Exp Med 1996; 184: 799-802.
34. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
35. del Pozo MA, Pulido R, Munoz C, et al. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolitic shedding mechanism. Eur J Immunol 1994; 24: 2586-2594.
36. Gearing AJW, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
37. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 1995; 155: 45-57.
38. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144: 4579-4586.
39. Damle NK, Klussman K, Linsley PS, Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J Immunol 1992; 148: 1985-1992.
40. De Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994; 179: 619-629.
41. Van Seventer GA, Newman W, Shimizu Y, et al. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 1991: 174: 901-913.
42. Semnani RT, Nutman TB, Hochman P, Shaw S, van Seventer GA. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells. J Exp Med 1994; 180: 2125-2135.
43. Chirathaworn C, Tibbetts SA, Chan MA, and Benedict SH. Cross-linking of ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J Immunol 1995; 155: 5479-5482.
44. De Fougerolles AR, and Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175: 185-190.
45. Hernandez-Caselles T, Rubio G, Campanero MR, et al. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. Eur J Immunol 1993; 23: 2799-2806.
46. Binnerts ME, van Kooyk Y, Simmons DL , Figdor CG. Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur J Immunol 1994; 24: 2155-2160.
47. Azuma M, Phillips JH, Lanier LL. CD28-T lymphocytes. Antigenic and functional properties. J Immunol 1993; 150: 1147-1159.
48. Maraskovsky E, Troutt AB, Kelso A. Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8 + T cells and induces synthesis of IL-3 and IFN-γ but not IL-4 or IL-6. Int Immunol 1992; 4: 475-485.
49. Geissler D, Gaggl S, Most J, Greil R, Herold M, Dierich M. A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-α, interferon-γ and interleukin 1. Eur J Immunol 1990; 20: 2591-2596.
50. Agea E, Bistoni O, Bini P, et al. Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death. Allergy 1995; 50: 677-682.
51. Tohma S, Hirohata S, Lipsky PK. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation. J Immunol 1991; 146: 492-499.
52. Mishra GC, Berton MT, Oliver KG, Krammer PH, Uhr JW, Vitetta ES. A monoclonal anti-mouse LFA-1α antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1). J Immunol 1986; 137: 1590-1598.
53. Dustin M, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341: 619-624.
54. Wallace DL, Beverley PCL. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990; 69: 460-467.
55. Hviid L, Felsing A, Theander TG. Kinetics of human T-cell expression of LFA-1, IL-2 receptor, and ICAM-1 following antigenic stimulation in vitro. J Clin Lab Immunol 1993; 40: 163-171.
56. Andersson EC, Christensen JP, Marker O, Thomsen AR. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol 1994; 152; 1237-1245.
57. Ito M, Watanabe M, Kamiya H, Sakurai M. Changes of adhesion molecule (LFA-1, ICAM-1) expression on memory T cells activated with cytomegalovirus antigen. Cell Immunol 1995; 160: 8-13.
58. Schulz TF, Mitterer M, Neumayer HP, Vogetseder W, Dierich MP. Involvement in the initiation of T cell responses and structural features of an 85-kDa membrane activation antigen. Eur Immunol 1988; 18: 1253-1258.
59. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
60. Ganpule G, Knorr R, Miller JM, Carron CP, Dustin ML. Low affinity of cell surface lymphocyte function-associated antigen-1 (LFA-1) generates selectivity for cell-cell interactions. J Immunol 1997; 159: 2685-2692.
61. Shingu M, Hashimoto M, Nobunaga M, Isayama T, Yasutake C, Naono T. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients. Inflammation 1994; 18: 23-33.
62. Christensen JP, Johansen J, Marker O, Thomsen AR. Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. Clin Exp Immunol 1995; 102: 268-273.
63. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. Functional consequences on cell-mediated cytotoxicity. J Immunol 1991; 147: 4398-4401.
64. Becker JC, Termeer C, Schmidt RE, Brocker EB. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol 1993; 151: 7224-7232.
65. Roep BO, Heidenthal E, de Vries RRP, Kolb H, Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994; 343: 1590-1593.
66. Meyer DM, Dustin ML, Carron CP. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995; 155: 3578-3584.
67. Reilly PL, Woska JR, Jeanfavre DD, McNally E, Rothlein R, Bormann B-J. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol 1995; 155: 529-532.
68. Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990; 344: 70-72.
69. Crump CE, Arruda E, Hayden FG. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule. Antimicrob Agents Chemother 1994; 38: 1425-1427.
70. Hansel T, Braunstein J, Walker C, et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991; 86: 271-277.
71. De Rose V, Rolla G, Bucca C, et al. Intercellular adhesion molecule-1 is upregulated on peripheral blood T lymphocyte subsets in dual asthmatic responders. J Clin Invest 1994; 94: 1840-1845.
72. Bentley AM, Durham SR, Robinson DS, et al. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol 1993; 92: 857-868.
73. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993; 148: 689-694.
74. Ohkawara Y, Yamauchi K, Maruyama N, et al. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am J Respir Cell Mol Biol 1995; 12: 4-12.
75. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93: 1411-1421.
76. Gosset P, Tillie Leblond I, Janin A, et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and nonallergic asthmatic patients. Int Arch Allergy Immunol 1995; 106: 69-77.
77. Montefort S, Roche WR, Howarth PH, et al. Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Respir J 1992; 5: 815-823.
78. Montefort S, Feather IH, Wilson SJ, Haskard DO, Holgate ST, Howarth PH. The expression of leucocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992; 7: 393-398.
79. Manolitsas ND, Trigg CJ, McAulay AE, et al. The expression of intercellular adhesion molecule-1 and the β1-integrins in asthma. Eur Respir J 1994; 7: 1439-1444.
80. Bentley AM, Durham SR, Kay AB. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Invest Allergol Clin Immunol 1994; 4: 222-232.
81. Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995; 107: 99-102.
82. Metzger L, Lad P, Kalunta C, Goldberg B, Kaplan M. HLA-DR and ICAM-1 expression in normal and asthmatic subjects. J Allergy Clin Immunol 1992; 89: 146A.
83. Kenedy JD, Hatfield CA, Fidler SF, et al. Phenotypic characterization of T lymphocytes emigrating into lung tissue and the airway lumen after antigen inhalation in sensitized mice. Am J Respir Cell Mol Biol 1995; 12: 613-623.
84. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, and Springer TA. A cell adhesion molecule. ICAM-1 is the major surface receptor for rhinoviruses. Cell 1989; 56: 849-853.
85. Johnston SL, Pattemore PK, Sanderson G, et al. A community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995; 310: 1225-1228.
86. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982-986.
87. Hashimoto S, Imai K, Kobayashi T, et al. Elevated levels of soluble ICAM-1 in sera from patients with bronchial asthma. Allergy 1993; 48: 370-372.
88. Kobayashi T, Hashimoto S, Imai K, et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 1994; 96: 110-115.
89. Montefort S, Lai CKW, Kapahi P, et al. Circulating adhesion molecules in asthma. Am J Respir Crit Care Med 1994; 149: 1149-1152.
90. Takahashi N, Liu MC, Proud D, Yu X-Y, Hasegawa S, Spannhake EW. Soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am J Respir Crit Care Med 1994; 150: 704-709.
91. Cairns J, Walls A. Mast cell tryptase is a mitogen for epithelial cell. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996; 156: 275-283.
92. Chihara J, Yamamoto T, Kurachi D, Kakazu T, Higashimoto I, Nakajima S. Possible release of eosinophil granule proteins in response to signaling from intercellular adhesion molecule-1 and its ligands. Int Arch Allergy Immunol 1995; 108 (Suppl.): 52-54.
93. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
94. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456-459.
95. Nakao A, Nakajima H, Tomioka H, Nishimura T, Iwamoto I. Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosinophil recruitment into the mouse airways. J Immunol 1994; 153: 5819-5825.
96. Sun J, Elwood W, Haczku A, Barnes PJ, Hellewell PG, Chung KF. Contribution of intercellular adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitised Brown-Norway rats. Int Arch Allergy Immunol 1994; 104: 291-295.
97. Huguenel ED, Cohn D, Dockum DP, et al. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am J Respir Crit Care Med 1997; 155: 1206-1210.
98. Papi A, Holgate ST, Johnston SL. Loratidine modulates rhinovirus-induced ICAM-1 upregulation on pulmonary epithelial cells. Eur Respir J 1997; 10: Suppl. 25, 265s (abstract).
99. Vignola AM, Crampette L, Mondain M, et al. Inhibitory activity of loratidine and descarboethoxyloratidine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995; 50: 200-203.
100. Staquet MJ, Reano A, Schmitt D, Czarlewski W. Loratidine downregulates ICAM-1 expression on human keratinocytes and Langerhans cells. Eur J Dermatol 1996; 6: 369-372.